Caprine Serum Fraction, Immunomodulator
Cat. #63321 10 x 2ml 10 x
VETERINARY USE ONLY
INDICATIONS: For use as an
aid in the treatment of horses with Lower Respiratory Disease. To
be used in combination with adjunctive therapy.
Contains phenol and thimerosal as
The complex nature of Lower Respiratory Disease makes treatment
difficult for veterinarians who commonly prescribe antibiotics,
anti-inflammatory drugs, bronchodialators, and expectorants. Cases
often improve during treatment, but conditions can rapidly reoccur
when treatment is stopped – extending recovery time and delaying
a return to full health.
To address chronic and
reoccurring cases of Lower Respiratory Disease, Pulmo-Clear works
to modulate the immune system – allowing the horse improved
recovery from the clinical conditions associated with ELRD.
Corticosteroids and other drugs which may cause immunosuppression
are not recommended for use with this product.
DIRECTIONS: Store at 2° to 7°
C. Do not freeze. Use entire contents when first opened. Do not
vaccinate within 21 days before slaughter.
reaction may occur following administration of products of this
nature. If noted, administer adrenalin or equivalent.
In the event of accidental human
exposure, consult a physician.
DOSAGE AND ADMINISTRATION:
Inject one 2ml. dose deep intramuscularly in the neck. Repeat this
dose in 7-10 days in the opposite side of the neck. Moderate
exercise aids in preventing or reducing local reaction.
Discontinue use if a severe local reaction occurs.
Proper diagnosis, selection of
treatment modalities, and follow-up examinations for Lower
Respiratory Disease in equines require veterinary expertise.
Therefore, it is recommended that Pulmo-Clear be used by or under
the supervision of a veterinarian.
Efficacy studies demonstrate that
Pulmo-Clear [Caprine Serum Fraction, Immunomodulator], when
used with adjunctive therapy, successfully clears Equine Lower
Respitory Disease (ELRD), leading to increased recovery rates and
reduced recovery times in affected horses.* In fact, combined data
from field studies show that Pulmo-Clear helps promote an
overall ELRD recovery rate as high as 86 percent.*
A diagnosis of lower airway disease should be
based upon history, clinical examination and endoscopic findings
of exudate in the trachea.
*Contact PBC for summary study